Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2 by Huo, J, Le Bas, A, Ruza, RR, Duyvesten, HME, Mikolajek, H, Malinauskas, T, Tan, TK, Rijal, P, Dumoux, M, Ward, PN, Ren, J, Zhou, D, Harrison, PJ, Weckener, M, Clare, DK, Vogirala, VK, Radecke, J, Moynié, L, Zhao, Y, Gilbert-Jaramillo, J, Knight, ML, Tree, JA, Buttigieg, KR, Coombes, N, Elmore, MJ, Carroll, MW, Carrique, L, Shah, PNM, James, W, Townsend, AR, Stuart, DI, Owens, RJ, Naismith, JH

Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient by Zhou, D, Duyvesteyn, HME, Chen, C-P, Huang, C-G, Chen, T-H, Shih, S-R, Lin, Y-C, Cheng, C-Y, Cheng, S-H, Huang, Y-C, Lin, T-Y, Ma, C, Huo, J, Carrique, L, Malinauskas, T, Ruza, RR, Shah, PNM, Tan, TK, Rijal, P, Donat, RF, Godwin, K, Buttigieg, KR, Tree, JA, Radecke, J, Paterson, NG, Supasa, P, Mongkolsapaya, J, Screaton, GR, Carroll, MW, Gilbert-Jaramillo, J, Knight, ML, James, W, Owens, RJ, Naismith, JH, Townsend, AR, Fry, EE, Zhao, Y, Ren, J, Stuart, DI, Huang, K-YA